key: cord-0960436-hugna94r
authors: Stott, Robert J; Foster, Toshana L
title: Inhibition of arenavirus entry and replication by the cell-intrinsic restriction factor ZMPSTE24 is enhanced by IFITM antiviral activity
date: 2021-04-12
journal: bioRxiv
DOI: 10.1101/2021.04.12.439453
sha: 6e0fffabda8d40cd19620f5f0660ab7f440b2d93
doc_id: 960436
cord_uid: hugna94r

In the absence of effective vaccines and treatments, annual outbreaks of severe human haemorrhagic fever caused by arenaviruses, such as Lassa virus, continue to pose a significant human health threat. Understanding the balance of cellular factors that inhibit or promote arenavirus infection may have important implications for the development of effective antiviral strategies. Here, we identified the cell-intrinsic zinc transmembrane metalloprotease, ZMPSTE24, as a restriction factor against arenaviruses. Notably, CRISPR-Cas9-mediated knockout of ZMPSTE24 in human alveolar epithelial A549 cells increased arenavirus glycoprotein-mediated viral entry in pseudoparticle assays and live virus infection models. As a barrier to viral entry and replication, ZMPSTE24 may act as a downstream effector of interferon-induced transmembrane protein (IFITM) antiviral function; though through a yet poorly understood mechanism. Overexpression of IFITM1, IFITM2 and IFITM3 proteins did not restrict the entry of pseudoparticles carrying arenavirus envelope glycoproteins and live virus infection, yet depletion of IFITM protein expression enhanced virus entry and replication. Furthermore, gain-of-function studies revealed that IFITMs augment the antiviral activity of ZMPSTE24 against arenaviruses, suggesting a cooperative effect of viral restriction. We show that ZMPSTE24 and IFITMs affect the kinetics of cellular endocytosis, suggesting that perturbation of membrane structure and stability is likely the mechanism of ZMPSTE24-mediated restriction and cooperative ZMPSTE24-IFITM antiviral activity. Collectively, our findings define the role of ZMPSTE24 host restriction activity in the early stages of arenavirus infection. Moreover, we provide insight into the importance of cellular membrane integrity for productive fusion of arenaviruses and highlight a novel avenue for therapeutic development. Author Summary Increased human travel, virus genome evolution and expansion of the host rodent reservoir outside of endemic areas has contributed to increasing cases of the highly fatal arenaviral haemorrhagic disease, Lassa fever in Western Africa. These annual seasonal outbreaks present a serious global public health and socioeconomic burden, particularly in the absence of approved vaccines and antiviral countermeasures. Development of novel and effective therapeutic strategies against arenavirus infection is reliant on a better understanding of the molecular mechanisms of key host–virus interactions that antagonise or potentiate disease pathogenesis. We demonstrate the inhibition of arenavirus infection by the antiviral restriction factor ZMPSTE24 and describe a cooperative action with the innate immunity-stimulated family of interferon-induced transmembrane proteins (IFITMs). This work adds to our understanding of the mechanism of ZMPSTE24 and IFITM-mediated restriction of enveloped viruses and importantly suggests that these proteins may play a significant role in the pathogenesis of arenavirus infections.

In the absence of effective vaccines and treatments, annual outbreaks of severe 18 human haemorrhagic fever caused by arenaviruses, such as Lassa virus, continue to 19 pose a significant human health threat. Understanding the balance of cellular factors 20 that inhibit or promote arenavirus infection may have important implications for the 21 development of effective antiviral strategies. Here, we identified the cell-intrinsic zinc 22

transmembrane metalloprotease, ZMPSTE24, as a restriction factor against 23 arenaviruses. Notably, CRISPR-Cas9-mediated knockout of ZMPSTE24 in human 24 alveolar epithelial A549 cells increased arenavirus glycoprotein-mediated viral entry 25 in pseudoparticle assays and live virus infection models. As a barrier to viral entry and 26

replication, ZMPSTE24 may act as a downstream effector of interferon-induced 27 transmembrane protein (IFITM) antiviral function; though through a yet poorly 28 understood mechanism. Overexpression of IFITM1, IFITM2 and IFITM3 proteins did 29 not restrict the entry of pseudoparticles carrying arenavirus envelope glycoproteins 30 and live virus infection, yet depletion of IFITM protein expression enhanced virus entry 31 and replication. Furthermore, gain-of-function studies revealed that IFITMs augment 32 the antiviral activity of ZMPSTE24 against arenaviruses, suggesting a cooperative 33 effect of viral restriction. We show that ZMPSTE24 and IFITMs affect the kinetics of 34 cellular endocytosis, suggesting that perturbation of membrane structure and stability 35 is likely the mechanism of ZMPSTE24-mediated restriction and cooperative 36 ZMPSTE24-IFITM antiviral activity. Collectively, our findings define the role of 37 ZMPSTE24 host restriction activity in the early stages of arenavirus infection. agent of human Lassa Fever (LF) and is associated with significant mortality and 79 morbidity in affected West African countries. Increased human interactions with the 80 rodent host reservoir, mainly Mastomys natalensis, have led to the emergence and re-81 emergence of LF disease (6-9). Particularly Nigeria reports continued outbreaks of LF, 82 resulting in tens of thousands of cases and lead to case fatality rates as high as 30% 83 (10, 11). Recent expansion of LASV outside of endemic regions has further highlighted 84 in the presence of ZMPSTE24 augmented restriction of arenavirus entry and 166 replication and showed that ZMPSTE24 and IFITM3 can alter cellular endocytosis 167 rates possibly by impacting on the rigidity of cell membranes in an independent or 168 cooperative manner. Collectively, our results provide strong support that arenaviruses 169 utilise an endocytic pathway that is sensitive to ZMPSTE24 restriction and is enhanced 170 upon recruitment of IFITM3. 171

The broad-spectrum intrinsic restriction factor ZMPSTE24 blocks the endocytic entry 174 of a number of enveloped viruses (33). We used arenavirus GP-pseudoparticles 175 (GPpp) generated from a panel of OW (LCMV, LASV, LUJV, MOPV) and NW (JUNV, 176 MACV, CHAPV) mammarenavirus representatives to examine the role of ZMPSTE24 177 restriction during arenavirus entry. Specifically, murine leukaemia virus (MLV) 178 packaging a green fluorescent protein (GFP) reporter was pseudotyped with different 179 arenavirus GP proteins. Using flow cytometry analysis, we first investigated the 180 infectivity of these arenavirus GPpp in A549 human lung epithelial cells stably over-181 expressing FLAG-tagged ZMPSTE24 compared to vector control cells. Entry of both 182 OW and NW arenavirus GPpp were similarly susceptible to restriction by 183 overexpression of ZMPSTE24 ( Fig 1A) . To examine the importance of ZMPSTE24 184 metalloprotease activity in the restriction of arenavirus GPpp entry, we mutated 185 histidine residue 335 within the essential, conserved HEXXH zinc metalloprotease 186 catalytic motif and demonstrated that the H335A mutant also displayed comparable 187 restriction of LCMVpp and LASVpp infection to wild-type ZMPSTE24 in A549 cells 188 when compared with vector only controls, albeit to a slightly lesser extent ( Fig 1B) . Therefore, the combined data suggest that ZMPSTE24 impedes arenavirus infection 190 but that this viral restriction activity is largely independent of its protease function. To corroborate the inhibitory effect of ZMPSTE24 on the entry of arenaviruses, we 193 silenced the expression of ZMPSTE24 by performing siRNA knockdown (KD) studies 194 in A549 cells. We found that LCMVpp and LASVpp infection was enhanced 2.5-fold in 195 ZMPSTE24 KD cells compared to the scramble control siRNA (Fig 1C) . To build on 196 the siRNA knockdown data, given that the knockdown by western blot was apparently 197 not complete, we depleted the expression of ZMPSTE24 in A549 cells using Cas9 lentiviral vectors. Cells were screened by western blotting to confirm the 199 depletion of ZMPSTE24 expression in the knockout (KO) cells. Infection by most OW 200 and NW arenavirus GPpp was markedly increased in the ZMPSTE24 knockout cells 201 compared to unmodified control cells ( Fig 1D) . To further confirm the role of 202 ZMPSTE24 as an intrinsic host factor against arenavirus GPpp entry, we modified the 203 ZMPSTE24 KO A549 cells to stably express C-terminally FLAG-tagged ZMPSTE24 204 by retroviral transduction (Fig 1E) . We observed less infection with LCMVpp and 205

LASVpp in the ZMPSTE24-expressing cells compared to the ZMPSTE24 KO cells. 206

Collectively, by using single-round GPpp infection assays, we have identified 207 ZMPSTE24 as a host restriction factor against arenavirus entry. 208

It has been suggested that ZMPSTE24 is recruited to endocytic compartments by 212 IFITM proteins, thereby blocking the endocytic entry of enveloped viruses (33, 34). We 213 aimed to examine the role that IFITMs play in the restriction activity against 214 arenaviruses. As IFITMs are induced by IFN stimulation, we first assessed the antiviral 215 effects of exogenous IFN1 on the early stages of arenavirus infection in A549 cells. 216

As measured by flow cytometry, single-round infectivity of GPpp across OW and NW 217 strains was markedly reduced in cells incubated with 1000U/ml universal IFN1, 218

suggesting an IFN-mediated inhibition of arenavirus entry (Fig 2A) . It has previously 219 been reported that arenaviruses are not susceptible to inhibition by the broadly acting 220 IFN1-stimulated family of IFITM proteins (39, 48) . To further validate this, we 221 generated A549 cells stably expressing individual human IFITM1, IFITM2 and IFITM3 222 proteins at levels similar in magnitude to that induced by IFN1 treatment (Fig 2B) . By 223 contrast, the expression of endogenous ZMPSTE24 was not upregulated following 224 treatment with IFN1. We analysed the infectivity of different arenavirus GPpp in these 225 cells and found that all strains tested were resistant to antiviral IFITM activity (Fig 2C) , 226 which is in agreement with previous studies (39, 48). Unpaired t-test *p<0.05. Data are expressed as mean ±SEM from experiments in triplicate.

To assess whether the depletion of endogenous IFITMs may alter the efficiency of 229 arenavirus GPpp infection, we used CRISPR-Cas9 lentiviral vectors to target IFITM 230 expression in A549 cells. As observed by western blotting, the IFITM3 guide RNA 231 (gRNA) used resulted in effective depletion of the specific IFITM targeted but also 232 resulted in the depletion of IFITM2 and IFITM1, given their high degree of homology, 233 chromosomal positioning and close proximity ( Fig 2D) . Knockout of endogenous 234

that IFITMs may contribute to the inhibition of arenavirus GP-mediated viral entry, 236 possibly through co-factor interactions ( Fig 2E) . 237 238

To address the effects of IFITMs on ZMPSTE24 activity, we first assessed the 240 comparative localisation of the host restriction factors. Immunofluorescence 241 microscopy imaging showed that overexpressed HA-tagged ZMPSTE24 possesses a 242 cytoplasmic distribution and predominantly localises to endosomal compartments in 243 A549 cells. Further, we found that ZMPSTE24 co-localises with the early endosome 244 marker, EEA1 and to a lesser extent with the late endosome marker Rab9, but does 245 not localise to the lysosome marker LAMP1 (Fig S1) . The localisation of IFITM proteins 246 is thought to define the spectrum of viruses that these antiviral factors restrict (23). 247 IFITM1 is mostly localised to the plasma membrane, whilst IFITMs 2 and 3, like 248 ZMPSTE24, are localised to endosomal compartments due to the presence of a 249 conserved endocytic localisation motif (21, 23). We further demonstrated by confocal 250 microscopy imaging that endogenous ZMPSTE24 co-localises with all three HA-251 tagged IFITM proteins when overexpressed in A549 cells ( Fig 3A) . In the presence of 252 IFITM1, ZMPSTE24 redistributed to the plasma membrane and IFITM1 was also 253 found to have a disperse intracellular punctate distribution that overlapped with 254 ZMPSTE24. This observation implies a cooperative function or interaction of the two 255 proteins ( Fig 3A) . Considering these observations, we next corroborated that IFITMs 256 and ZMPSTE24 interact (33, 34). A549 cells were transfected with C-terminally FLAG-257 tagged ZMPSTE24. Proteins were captured on beads coated with anti-IFITM2/3 258 antibody and analysed by western blot. IFITM proteins have the propensity to homo-259 and hetero-oligomerise and we found that ZMPSTE24-FLAG binds to the endogenous 260 IFITM1, 2 and 3 proteins ( Fig 3B) (41). Complementary to these co-261 immunoprecipitation data, we assessed the interaction between ZMPSTE24 and 262 specifically, IFITM3, in live cells using a NanoLuc Binary Technology (NanoBiT)-based 263 assay ( Fig 3C) . NanoLuc Luciferase is split into two complementary segments, 18kDa 264

Large BiT (LgBiT) and 1.3kDa Small BiT (SmBiT); these possess low intrinsic affinity 265 for each other. However, a bright luminescent signal is restored upon interaction of 266 the binding partners to which they are fused. We engineered ZMPSTE24 and IFITM3 267 constructs tagged at either the N or C terminus with SmBiT and LgBiT fragments ( indicating the oligomerisation of IFITM proteins (Fig 3C) . We found that C-terminal 278 tagged ZMPSTE24 (ZMPSTE24-C-S) and IFITM3 (IFITM3-C-L) in combination 279 produced a luminescent signal approximately 12-fold higher than that of the negative 280 control pairs and approaching the signal of the N-L-IFITM3/N-S-IFITM3 combination 281 ( Fig 3C) . Thus, these data are in keeping with previous findings that suggest the two 282 host restriction factors may interact (33). LCMVpp and LASVpp infection ( Fig 4B) . Interestingly, when we examined A549 cells 292 overexpressing ZMPSTE24 and IFITM3 in combination, we found that ZMPSTE24 co-293 expression led to a redistribution of IFITM3 from the disparate endo-cytoplasmic 294 localisation to a distinct endosomal localisation that overlaps with ZMPSTE24 295 expression ( Fig 4B) . Thus, we speculate that this redistribution of IFITM3 likely 296 influences the observed enhancement in ZMPSTE24 restriction of arenavirus entry. We next generated A549 lentiviral non-targeting (NT) control and CRISPR-Cas9 299 IFITM knockout cells and stably expressed ZMPSTE24-FLAG in these cells. 300

in IFITM KO cells (Fig 4C) . Overexpression of ZMPSTE24 in NT control cells 302 abrogated LCMVpp and LASVpp infection but in the absence of IFITM expression, the 303 sensitivity of arenavirus entry to ZMPSTE24 restriction was decreased (Fig 4C) . 304

Taken together, our data show that ZMPSTE24 interacts with IFITM proteins and 305

importantly suggest a cooperative impairment of arenavirus entry in which ZMPSTE24 306 appears to co-opt IFITM3 to facilitate restriction of arenavirus entry. 307 308

We established that ZMPSTE24 can restrict the early stages of arenavirus infection 310 through the use of GPpp infection assays and found that ZMPSTE24 interaction with 311 IFITM proteins markedly increased the sensitivity of arenavirus-mediated entry to 312 ZMPSTE24, suggesting a cooperative function. The replication of MOPV is highly 313 sensitive to IFN1 inhibition, thus we next wanted to determine whether IFITM-314 mediated restriction contributed to this inhibition and to assess the impact of 315 ZMPSTE24 on live virus replication (Fig 5A) . Using lentiviral CRISR-Cas9 ZMPSTE24 316 gRNA and siRNAs against IFITMs 1, 2 and 3, we first knocked out or knocked down 317 endogenous protein expression from A549 cells and challenged the cells with MOPV 318 (Fig 5B, C) . Levels of MOPV NP and L RNA in these cells were quantified by RT-319 qPCR at 72 hours post-infection. We found that ZMPSTE24 depletion markedly 320 increased the level of viral replication observed. This was reflected in the 4-6-fold 321 increase in MOPV NP and L RNA levels in the absence of ZMPSTE24 expression, 322

indicating that in these cells ZMPSTE24 is likely a component of the induced antiviral state upon arenavirus infection (Fig 5B) . Likewise, knockdown of IFITM protein 324 expression, particularly of IFITMs 2 and 3 significantly enhanced MOPV NP and L 325 RNA levels (Fig 5C) . h. Unpaired t-test ****p<0.0001, ** p<0.01, *p<0.05. All samples were collected by RNA extraction and cDNA synthesis before analysing by RT-qPCR with primers for MOPV L and NP genes. Data was analysed by the 2 ΔΔ Ct method with primers for reference genes β-actin and GAPDH. Values are expressed as means ±SEM relative to controls of samples performed in triplicate.

To further address the effects of ZMPSTE24 and IFITM activity on live virus replication, 327

we generated stable A549 cell lines expressing each human IFITM protein, 328 ZMPSTE24 or expressing ZMPSTE24 in combination with IFITM3 ( Fig S3, Fig 5D) . 329

We then infected these cells with MOPV with a multiplicity of infection (MOI) of 0.01, 330 and found that there was little to no sensitivity to IFITM protein expression but 331 significant sensitivity to ZMPSTE24. The reduction of MOPV gene expression in cells 332 expressing ZMPSTE24 was further enhanced when IFITM3 was co-expressed (Fig  333   5D ). Both single round arenavirus GPpp assays and multicycle replication studies with 334 live MOPV v therefore show sensitivity to ZMPSTE24 restriction that is specifically 335 enhanced in the presence of IFITM3 expression. These data are highly suggestive of 336 an antiviral role of ZMPSTE24 and the IFITM cofactors in arenavirus cellular entry. 337

The molecular mechanism of ZMPSTE24 and IFITM antiviral activity are not well We therefore used AmphoB treatment to analyse whether membrane modulation is 351 required for ZMPSTE24 restriction and for the cooperative antiviral activity of 352 ZMPSTE24 and IFITM proteins. To address this, we used CRISPR-Cas9 ZMPSTE24 353 KO A549 cells that overexpressed either ZMPSTE24 or IFITM3 individually, or 354 overexpressed both proteins in combination (Fig S2, Fig 6A) . We infected these cells 355 and CRISPR-Cas9 NT control cells with our panel of arenavirus GPpp namely LCMV, 356 LASV, MOPV, LUJV, JUNV, MACV and CHAPV. Notably, AmphoB had no effect on 357 arenavirus GPpp infection in NT controls. We observed that AmphoB produced a 358 broadly significant reversal of ZMPSTE24-mediated restriction of arenavirus GPpp 359 infection, rendering these cells less sensitive to ZMPSTE24 inhibition ( Fig 6A) . 360

Furthermore, AmphoB limited the cooperative restriction of ZMPSTE24 and IFITM3 in 361 comparison to untreated cells (Fig 6A) . These data imply that at the early stages of 362 arenavirus infection, the modulation of cellular membrane integrity is critical for the 363 antiviral activity of ZMPSTE24 and the observed restriction enhancement in the 364 presence of IFITM3. To examine this during live virus infection, we infected these cells 365 with MOPV at MOI 0.01 for 72 hrs and quantified levels of MOPV L and NP gene 366 expression. We found that AmphoB increased the sensitivity of MOPV to ZMSPTE24 367 alone and when expressed in combination with IFITM3 ( Fig 6B) . Similar to arenavirus GPpp infection (Fig 6A) , expression of IFITM3 alone did not affect MOPV replication. 369 Furthermore, we also observed no change in MOPV L and NP gene expression levels 370 upon AmphoB treatment in these cells. 371 internalisation. In contrast to control cells, the rate and intensity of FM™2-10 probe 385 incorporation, characteristic of membrane endocytosis, was reduced in the presence 386 of IFITM3 or ZMPSTE24 and this reduction was significantly enhanced upon co-387 expression of the two restriction factors (Fig 6C) . These findings strengthen the argument that ZMPSTE24 and IFITMs cause changes in membrane structure and 389 dynamics that likely impact on the efficiency of virus fusion. impacted by ZMPSTE24 activity suggests a universal antiviral mechanism that occurs 412 prior to virus fusion. Our data suggests that disrupting the protease activity of ZMPSTE24 does not alter the sensitivity of arenaviruses to restriction, further implying 414 a generalised mechanism of restriction that may involve modifying host cell membrane 415

properties to inhibit fusion pore formation. This mechanism which impairs endosomal 416 viral membrane fusion is likely facilitated by the IFITM proteins as co-factors of 417 ZMPSTE24 activity. 418

The localisation of IFITM proteins is an important determinant of the breadth of viruses 419 that they restrict. IFITM1 is found predominantly at the plasma membrane whilst 420 IFITMs 2 and 3 localise to endosomal compartments (21). We confirmed and 421 expanded previous studies that show arenaviruses are insensitive to IFITM restriction 422 (39). However, our observations also highlight that arenavirus entry and replication is 423 enhanced upon knock down and knockout of IFITM expression. This implies that 424

A recent studiy by Suddala et al. (39) indicated that IFITM3 restricts through a 426 proximity-based mechanism and that LASV may escape restriction by IFITM3 by 427 entering cells through a distinct endosomal pathway lacking IFITM3 expression. Our 428 observations support that arenaviruses are not inherently insensitive to IFITM 429 restriction given that IFITM depletion enhances arenavirus infection (39). 430

In light of our findings and given that previous studies have showed that ZMPSTE24 431 is required for the antiviral activity of IFITMs, we explored a possible cooperative role 432 of ZMPSTE24 and IFITMs against arenavirus infection. Our data demonstrate that 433 endogenous ZMPSTE24 co-localises with all three IFITM proteins when they are 434 ectopically expressed in A549 cells. Using immunoprecipitation and complementation 435 assays, we also showed that IFITM proteins interact with ZMPSTE24. 436

In our present study, we provide strong evidence for the biological significance of the 437 ZMPSTE24-IFITM interaction demonstrating that engagement with IFITM proteins enhances the sensitivity of arenaviruses to ZMPSTE24-mediated restriction. 439

Specifically, we show that stable ectopic expression of ZMPSTE24 with IFITM3 440 significantly enhanced inhibition of arenavirus entry and replication. In addition, we 441 found that in contrast to cells singly overexpressing IFITM3, ectopic co-expression of 442 IFITM3 with ZMPSTE24 in A549 cells led to the redistribution of IFITM3 to distinct 443 endosomal compartments that were positive for ZMPSTE24. We therefore propose 444 the redistribution of IFITM3 to a ZMPSTE24-positive pathway along which 445 arenaviruses enter and fuse, induces an enhanced modification of cellular membranes 446 that thus impairs virus fusion. Supporting this hypothesis, we provide evidence that 447 the absence of IFITMs in A549 cells expressing ZMPSTE24 leads to a reduction in 448 the sensitivity of arenavirus GPpp to ZMPSTE24-mediated restriction. It is therefore 449 tempting to speculate that ZMPSTE24 is able to modulate the intracellular trafficking 450 of its IFITM co-factors to an early endosomal localisation that increases the 451 susceptibility of normally IFITM-resistant viruses like arenaviruses. 452

We aimed to address the mechanism of ZMPSTE24 restriction and of the observed stimulation was performed using 1000 U ml −1 for 4 h before immunoblotting. 507

The NanoBiT split luciferase system was used to assess interaction of IFITM3 and 508 ZMPSTE24. Briefly IFITM3 and ZMPSTE24 were fused to the NanoBiT large (LgBiT) 509 or small (SmBiT) subunits of NanoLuc luciferase at the N or C terminus. The coding 510 region of IFITM3 was amplified by PCR with added XhoI and NheI restriction sites 511

whereas ZMPSTE24 was amplified with BglII and XhoI sites. Primers used were as 

The UVE/MOPV/UNK/MZ/Mozambique 20410 strain of MOPV was obtained from 527 replaced and the cells incubated for a further 72 h at 37°C after which they were 539 harvested for total RNA extraction. For interferon treatment, cells were treated with 540 1000 U ml −1 IFN-α (universal type 1 IFN, PBL Interferon Source) for 4 h before 541 infection. Media was changed before infection with MOPV as above. To assess the 542 effect of amphotericin B on the restriction of MOPV replication by ZMPSTE24 and the 543 cooperative action with IFITMs, the relevant stable A549 cell lines were treated with 1 544 µM amphotericin B (Sigma Aldrich) for 1 h at 37°C prior to infection and following 545 infection with MOPV. 546

To produce arenavirus GP retroviral pseudoparticles, encoding GFP, 293T cells were 549 transfected with pCMV-MLV gag-pol, the pCMV-MLV GFP encoding an MLV-based 550 transfer vector containing a CMV-GFP internal transcriptional unit (kindly gifted by 551

Professor Jonathan Ball) and the pI.18 plasmid encoding the arenavirus GP of interest, 552 at a ratio of 0.6:0.9:0.6 µg. Cells were transfected using 1 mg/ml PEI MAX® 553 

Cells are gently washed, detached and resuspended in 1% BSA in PBS and 0.1% 571 (w/v) sodium azide. Flow cytometry analyses were performed using a BD FACSCanto 572 II flow-cytometer (Becton Dickinson), collecting 10,000 events, and analysed using 573 

Comparative analysis of disease pathogenesis 719 and molecular mechanisms of New World and Old World arenavirus infections

Interrelationships among arenaviruses 722 measured by indirect immunofluorescence

Molecular phylogeny of the arenaviruses

Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-730 associated arenavirus from southern Africa

Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria

Metagenomic sequencing at the epicenter of the Nigeria

Genetic characterization of Lassa virus 749 strains isolated from 2012 to 2016 in southeastern Nigeria

Analysis of Lassa Virus during an Increase in Cases in Nigeria

Lassa 762 Fever: Epidemiology, Clinical Features, Diagnosis

Public health response to two imported, epidemiologically 774 related cases of Lassa fever in the Netherlands (ex Sierra Leone)

New Lineage of Lassa Virus

Genome Sequence of Lassa Virus Isolated 786 from the First Domestically Acquired Case in Germany

A 789 Vaccine Platform against Arenaviruses Based on a Recombinant 790

Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins

Protection of rhesus monkeys from 793

Lassa virus by immunisation with closely related Arenavirus

Experimental infection of rhesus monkeys with Lassa virus and a closely 796 related arenavirus, Mozambique virus

Diagnostics for Lassa fever virus: a 798 genetically diverse pathogen found in low-resource settings

Intrinsic immunity: a front-line defense against viral attack

Resistance of Transmitted Founder HIV-804 1 to IFITM-Mediated Restriction

Opposing 807 activities of IFITM proteins in SARS-CoV-2 infection

More than meets the I: the diverse 809 antiviral and cellular functions of interferon

The polybasic cleavage site in the SARS-813

CoV-2 spike modulates viral sensitivity to Type I interferon and IFITM2

Virus entry. Lassa virus entry requires a trigger-induced receptor switch

Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike

Are Host Factors for Lujo Virus Cell Entry

Acidic pH Triggers Lipid Mixing 831 Mediated by Lassa Virus GP

Kinetics and pH dependence of acid-833 induced structural changes in the lymphocytic choriomeningitis virus 834 glycoprotein complex

From APOBEC to ZAP: Diverse mechanisms used by cellular 837 restriction factors to inhibit virus infections

Distinct Molecular Mechanisms of Host 840

Immune Response Modulation by Arenavirus NP and Z Proteins. Viruses 12

ZMPSTE24 defends against influenza and 842 other pathogenic viruses

ZMPSTE24 Is Downstream Effector of 844

The IFITM Proteins Mediate Cellular Resistance to Influenza 849

West Nile Virus, and Dengue Virus

IFITM3 851 restricts influenza A virus entry by blocking the formation of fusion pores 852 following virus-endosome hemifusion

Defining the Range of Pathogens Susceptible to Ifitm3 Restriction 856

Using a Knockout Mouse Model

IFITM-2 and IFITM-3 but not IFITM-1 860 restrict Rift Valley fever virus

Interferon-induced transmembrane protein 863 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-864 carrying endosomes

Membrane Topology Model for Human Interferon Inducible Transmembrane 867 Protein 1

The CD225 domain of IFITM3 is required for both IFITM protein association 871 and inhibition of influenza A virus and dengue virus replication

ZMPSTE24, an integral membrane zinc 874 metalloprotease with a connection to progeroid disorders

Role of the stable signal peptide of Junín arenavirus 877 envelope glycoprotein in pH-dependent membrane fusion

Transferrin 880 receptor 1 is a cellular receptor for New World haemorrhagic fever 881 arenaviruses

Different 883 mechanisms of cell entry by human-pathogenic Old World and New World 884 arenaviruses

GILT restricts the cellular entry mediated by the 887 envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus

Infectious Lassa virus, but not filoviruses, is restricted by BST-892 2/tetherin

Distinct Patterns of IFITM-896

Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus

IFITM proteins restrict 900 viral membrane hemifusion

Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection

Amphotericin 908 B increases influenza A virus infection by preventing IFITM3-mediated 909 restriction

Identification of Clotrimazole Derivatives as Specific 913 Inhibitors of Arenavirus Fusion

Two endocytic recycling routes 915 selectively fill two vesicle pools in frog motor nerve terminals

Lamp1 Increases 918 the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic 919

Endosomal Compartments

CRISPR-Cas9 gRNA sequences to target human ZMPSTE24 593 (CACAACTAATGTGAACAGCC) and a non-targeting control 594(GGCCCTCTAGAAAAGTCTCG) were generated in pLentiCRISPR v2 and gRNA 595 sequences to target human IFITMs 1, 2 and 3 (TTCTTCTCTCCTGTCAACAG) were 596 generated in eSpCas9-LentiCRISPR v2 (Genscript). Viral stocks were generated in 597 293T cells. 293T cells were co-transfected with psPAX2 (Addgene), pMD2.G VSV-g 598 and the eSpCas9-LentiCRISPRv2 construct targeting ZMPSTE24 or the IFITM 599 proteins or a non-targeting control at a ratio of 0.6:0.9:0.6 using 1 mg/ml PEI ® -MAX. All statistical analyses were carried out using GraphPad Prism v9.0.2. Levels of 701 significance were determined as follows: ****p<0.0001, *** p<0.001, ** p<0.01, 702 *p<0.05. Data was subjected to independent sample t-tests. 703

We are grateful to Professor Janet Daly for support and helpful advice. We thank 706Professor Jonathan Ball for helpful discussions. We are also grateful to Dr Thomas 707Strecker for advice and helpful suggestions. We thank Sam Stafford at Leeds Beckett 708University for his help with deconvolution of microscopy images. We also thank the 709